News | May 11, 2024
Dr. Lal PathLabs posts Q4 FY24 consolidated PAT at Rs. 84.5 Cr
The company has posted net profit of Rs.357.7 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.357.7 crores for the Financial Year ended March 31, 2024
The company has posted net profit) of Rs.18.88 crores for the Financial Year ended March 31, 2024
Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024
Piramal Pharma has reported total income of Rs. 2,578.74 crores during the period ended March 31, 2024
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
The company has posted net profit of Rs.8.29 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.118.82 crores for the Financial Year ended March 31, 2024
The product is used to treat amyotrophic lateral sclerosis
The company has posted net profit of Rs.171.42 crores for the Financial Year ended March 31, 2024
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
Subscribe To Our Newsletter & Stay Updated
